ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 767,32
0,42%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Trubion Pharmaceuticals (MM) (TRBN)

  7. Trubion Pharmaceuticals (MM) (TRBN) Actualités

TRBN

Trubion Pharmaceuticals (MM) (TRBN)

Trubion Pharmaceuticals (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TRBN
DateHeureSourceTitreSymboleSociété
29/10/201015h10Edgar (US Regulatory)Current report filing (8-K)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
29/10/201000h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
28/10/201023h15Edgar (US Regulatory)(25-NSE)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
21/10/201022h59Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
05/10/201017h46Business WireLevi & Korsinsky, LLP Announces Class Action Lawsuit against Trubion Pharmaceuticals, Inc. and Its Board of DirectorsNASDAQ:TRBNTrubion Pharmaceuticals (MM)
27/09/201022h10Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
27/09/201022h06Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
08/09/201022h00PR Newswire (US)Trubion Pharmaceuticals Announces Early Termination of HSR Waiting PeriodNASDAQ:TRBNTrubion Pharmaceuticals (MM)
07/09/201016h48Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
23/08/201022h43Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
17/08/201022h40Business WireLaw Office of Abe Shainberg Announces Investigation of Possible Breach of Fiduciary Duty by the Board of Trubion Pharmaceutic...NASDAQ:TRBNTrubion Pharmaceuticals (MM)
16/08/201022h02Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
16/08/201022h00PR Newswire (US)Trubion Pharmaceuticals Inc. Reports Second-Quarter and First-Half 2010 Financial ResultsNASDAQ:TRBNTrubion Pharmaceuticals (MM)
16/08/201019h38Business WireBull & Lifshitz, LLP Announces Investigation of the Acquisition of Trubion Pharmaceuticals, Inc.NASDAQ:TRBNTrubion Pharmaceuticals (MM)
16/08/201017h08Business WireThe Law Office of Vincent Wong Announces Investigation of Possible Breach of Fiduciary Duty by the Board of Trubion Pharmaceu...NASDAQ:TRBNTrubion Pharmaceuticals (MM)
14/08/201002h30Business WireLaw Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Trubion Pharmaceuticals, Inc.NASDAQ:TRBNTrubion Pharmaceuticals (MM)
13/08/201022h20Business WireRyan & Maniskas, LLP Announces Investigation of Trubion Pharmaceuticals, Inc.NASDAQ:TRBNTrubion Pharmaceuticals (MM)
13/08/201022h14Business WireKendall Law Group Investigates Trubion Pharmaceuticals, Inc. Acquisition for ShareholdersNASDAQ:TRBNTrubion Pharmaceuticals (MM)
13/08/201018h52Business WireThe Briscoe Law Firm, PLLC & Cash Powers Taylor, LLP Announce the Investigation of Possible Breaches of Fiduciary Duties Conc...NASDAQ:TRBNTrubion Pharmaceuticals (MM)
13/08/201018h49Business WireThe Law Office of Joseph Klein Announces Investigation of Possible Breach of Fiduciary Duty by the Board of Trubion Pharmaceu...NASDAQ:TRBNTrubion Pharmaceuticals (MM)
13/08/201013h00PR Newswire (US)Trubion Announces Dates for Second-Quarter and First-Half 2010 Earnings Conference CallNASDAQ:TRBNTrubion Pharmaceuticals (MM)
13/08/201005h05Business WireRobbins Umeda LLP Announces an Investigation of the Acquisition of Trubion Pharmaceuticals, Inc. by Emergent Biosolutions Inc.NASDAQ:TRBNTrubion Pharmaceuticals (MM)
12/08/201023h18Business WireLevi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Trubion Pharmaceuticals Inc. - TRBNNASDAQ:TRBNTrubion Pharmaceuticals (MM)
12/08/201022h15PR Newswire (US)Trubion Pharmaceuticals Announces Agreement to be Acquired by Emergent BioSolutionsNASDAQ:TRBNTrubion Pharmaceuticals (MM)
14/06/201022h00PR Newswire (US)Trubion Provides Update on Clinical Development in RANASDAQ:TRBNTrubion Pharmaceuticals (MM)
03/06/201022h00PR Newswire (US)Trubion Pharmaceuticals Wins Genentech and Biogen Idec Patent AppealNASDAQ:TRBNTrubion Pharmaceuticals (MM)
01/06/201022h00PR Newswire (US)Trubion Pharmaceuticals, Inc. to Present at 9th Annual Needham Healthcare ConferenceNASDAQ:TRBNTrubion Pharmaceuticals (MM)
12/05/201022h00PR Newswire (US)Trubion Pharmaceuticals, Inc. Announces Acceptance of Two Presentations on Its SBI-087 Product Candidate at EULAR 2010NASDAQ:TRBNTrubion Pharmaceuticals (MM)
06/05/201022h00PR Newswire (US)Trubion Pharmaceuticals, Inc. Reports First-Quarter 2010 Financial ResultsNASDAQ:TRBNTrubion Pharmaceuticals (MM)
29/04/201022h00PR Newswire (US)Trubion Announces Dates for First-Quarter 2010 Earnings Conference CallNASDAQ:TRBNTrubion Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:TRBN

Dernières Valeurs Consultées

USOTC
RITPF
RIT Capital Partners (PK)
LSE
SK15
Westpac 26 A
MRTX
DCNBTC
Dentacoin
LSE
35ML
Euro.bk.nts33
COIN
DARETH
Dalarnia
LSE
49NW
Granite Mas.b1
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés